{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-010941","form_type":"8-K","ticker":null,"cik":"0001292519","company_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.701115+00:00","generated_at":"2026-06-06T07:49:52.565552+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"InVivo Therapeutics receives Nasdaq delisting notice after Chapter 11 filing; trading to suspend Feb 13","bullets":["Filed Chapter 11 bankruptcy on Feb 1, 2024.","Nasdaq notified company of delisting on Feb 2, 2024, per Listing Rules 5101, 5110(b), IM-5101-1.","Company will not appeal; common stock to be suspended at opening of business on Feb 13, 2024.","Form 25-NSE will be filed removing securities from Nasdaq listing and registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-010941","json":"https://secwatch.observer/filing/0001104659-24-010941.json","markdown":"https://secwatch.observer/filing/0001104659-24-010941.md","text":"https://secwatch.observer/filing/0001104659-24-010941.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/0001104659-24-010941-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/tm245285d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:49:52.565552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c5f583fadce0d0c1f7054da87939fb899f118b7a","claim":"INVIVO THERAPEUTICS HOLDINGS CORP. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).","evidence_excerpt":"February 2, 2024, the Company received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Voluntary Petitions and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that the Company’s common stock will be delisted from Nasdaq. The Company does not intend to appeal this determination and, therefore, it is expected that its common stock will be delisted, which would not affect any actions it may take in bankruptcy. Nasdaq has informed the Company that trading of the C","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/0001104659-24-010941-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Rules","value":"5101, 5110(b), IM-5101-1"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}